0001654954-20-000310.txt : 20200110 0001654954-20-000310.hdr.sgml : 20200110 20200110213645 ACCESSION NUMBER: 0001654954-20-000310 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200108 FILED AS OF DATE: 20200110 DATE AS OF CHANGE: 20200110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NIFFENEGGER KATHI CENTRAL INDEX KEY: 0001620146 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37619 FILM NUMBER: 20522409 MAIL ADDRESS: STREET 1: C/O STELLAR BIOTECHNOLOGIES, INC. STREET 2: 332 EAST SCOTT STREET CITY: PORT HUENEME STATE: CA ZIP: 93041 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edesa Biotech, Inc. CENTRAL INDEX KEY: 0001540159 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 100 SPY COURT CITY: MARKHAM STATE: A6 ZIP: L3R 5H6 BUSINESS PHONE: (905) 475-1234 MAIL ADDRESS: STREET 1: 100 SPY COURT CITY: MARKHAM STATE: A6 ZIP: L3R 5H6 FORMER COMPANY: FORMER CONFORMED NAME: Stellar Biotechnologies, Inc. DATE OF NAME CHANGE: 20120120 4 1 section16.xml FORM 4 X0306 4 2020-01-08 0001540159 Edesa Biotech, Inc. EDSA 0001620146 NIFFENEGGER KATHI C/O EDESA BIOTECH, INC. 100 SPY COURT MARKHAM A6 L3R 5H6 ONTARIO, CANADA true Chief Financial Officer Common Shares 2020-01-08 4 A false 1218 4.11 A 1218 I By Trust Common Share Warrants (Right to Buy) 4.80 2020-01-08 4 A false 914 A 2020-07-08 2023-07-08 Common Shares 914 914 I By Trust Common Share Warrants (Right to Buy) 4.00 2020-01-08 4 A false 609 A 2020-07-08 2020-11-08 Common Shares 609 609 I By Trust The reported securities are included within 1,218 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share. Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023. Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020. /s/ Kathi Niffenegger 2020-01-10